Safari Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.70 M
as on 19-12-2024
- Paid Up Capital ₹ 2.68 M
as on 19-12-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 49.02%
(FY 2021)
- Profit -813.48%
(FY 2021)
- Ebitda 210.85%
(FY 2021)
- Net Worth -15.83%
(FY 2021)
- Total Assets -0.52%
(FY 2021)
About Safari Biotech
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.70 M and a paid-up capital of Rs 2.68 M, as per Ministry of Corporate Affairs (MCA) records.
Ganpatraj Chowdhary and Siddharth Chowdhary serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC046954
- Company No.
046954
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Safari Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Chowdhary  | Director | 20-Oct-2005 | Current |
| Ganpatraj Chowdhary | Director | 04-Sep-2015 | Current |
Financial Performance of Safari Biotech.
Safari Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 49.02% increase. The company also saw a substantial fall in profitability, with a 813.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Safari Biotech?
In 2021, Safari Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Rama Newsprint LimitedActive 33 years 6 monthsGanpatraj Chowdhary and Siddharth Chowdhary are mutual person
Riddhi Siddhi Estate Creator LlpActive 8 years 9 monthsGanpatraj Chowdhary and Siddharth Chowdhary are mutual person
- Riddhi Siddhi Gluco Biols LimitedActive 34 years 6 months
Ganpatraj Chowdhary and Siddharth Chowdhary are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Safari Biotech?
Unlock and access historical data on people associated with Safari Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Safari Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Safari Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
